Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

854 Cr

Lock In Period

N/A

Expense Ratio

2.3

Benchmark

BSE Healthcare Total Return

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Summary

Latest details for Aditya Birla Sun Life Pharma & Healthcare Fund Growth include a 31.4 NAV as of Mar 11,2026 and returns since inception of 93.76%. Minimum investments start at SIP ₹100. The Aditya Birla Sun Life Pharma & Healthcare Fund Growth AUM is ₹854 Cr, with a lock-in of N/A years, expense ratio of 2.3%, and benchmark BSE Healthcare Total Return. Exit load is - For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.. In the growth review for 1M Month/Year, the fund recorded 2.42% returns, against a category average of -1.05% and a category best of 5.39%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M2.42-1.055.39
6M0.162.018.52
1Y11.726.6216.30
3Y24.6714.66115.85

Portfolio Analysis

  • Equity: 97.96%
  • Debt: 2.03%
  • Others
As on: 2026-01-31
View allocation % by

1. Sun Pharmaceutical Industries Limited12.89%
2. Torrent Pharmaceuticals Limited5.00%
3. J.B. Chemicals & Pharmaceuticals Limited4.78%
4. Ajanta Pharmaceuticals Limited4.43%
5. Abbott India Limited4.39%
6. Aurobindo Pharma Limited4.33%
7. Lupin Limited4.14%
8. IPCA Laboratories Limited3.99%
9. Cipla Limited3.70%
10. Emcure Pharmaceuticals Ltd3.20%
11. Mankind Pharma Ltd2.63%
12. Alkem Laboratories Limited2.45%
13. CORONA Remedies Ltd2.13%
14. Shilpa Medicare Ltd1.98%
15. Divi's Laboratories Limited1.94%
16. SAI Life Sciences Ltd1.90%
17. ALEMBIC PHARMACEUTICALS LIMITED1.55%
18. Dr. Reddys Laboratories Limited1.48%
19. Jubilant Pharmova Ltd1.41%
20. Procter & Gamble Health Limited1.24%
21. Biocon Limited1.23%
22. Gland Pharma Limited1.14%
23. Piramal Pharma Ltd1.10%
24. Pfizer Limited1.02%
25. GlaxoSmithKline Pharmaceuticals Limited0.97%

1. Apollo Hospitals Enterprise Limited7.28%
2. Fortis Healthcare Limited3.96%
3. Jupiter Life Line Hospitals Ltd2.19%
4. Thyrocare Technologies Limited1.83%
5. METROPOLIS HEALTHCARE LIMITED1.55%
6. Suraksha Diagnostic Ltd1.10%
7. Vijaya Diagnostic Centre Limited0.92%
8. Max Healthcare Institute Limited0.82%

1. Medi Assist Healthcare Services Ltd1.28%

1. SANOFI CONSUMER HEALTHCARE1.12%

About Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹854 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.3. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundTata India Pharma & HealthCare Fund Growth9.229891.2163
This FundNippon India Pharma Fund Growth10.362792.1327
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth11.724993.7577
This FundSBI Healthcare Opportunities Fund Growth9.1532100.145
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth10.327110.3939

FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.3. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 2.42%
  • 6 Months : 0.16%
  • 1 Year : 11.72%
  • 3 Years : 24.67%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 31.4 as on Mar 11,2026. Since inception, the return has been 93.76%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹854 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500